Teladoc Health Inc (TDOC) Stock AnalysisTDOCTeladoc Health Inc

Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery. It operates in the Healthcare sector (SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE industry).

Teladoc Health Inc is currently not a good buy. The current price is $5.67, which is significantly below the analyst price target of $11 from Canaccord, indicating potential upside. However, the RSI is at 40.995, suggesting it is nearing oversold territory, but not yet a strong buy signal. The company has shown a decline in revenue, with a 4% drop year-over-year in Q2 to $606.9 million, and a net loss per share of $0.21, indicating ongoing financial struggles. The main risk is the forward P/E ratio of 303.03, which reflects high expectations that may not be met given the recent performance and competition in the healthcare sector.

13 analysts cover TDOC: 10 rate it Buy, 3 Hold and 0 Sell. The average price target is 8.91.